Early Treatment of Favipiravir in COVID-19 Patients Without Pneumonia: A Multicentre, Open-Labelled, Randomized Control Study is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 222489/Z/21/Z
National Institutes of Health
Grant: 5R01AI134091-05
Long acting NRTI therapies for HIV
National Institutes of Health
Grant: 5R24AI118397-10
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
Wellcome Trust
Grant: 222489
Design and implementation of a translational drug development platform for COVID-19 to generate preclinical evidence in support of treatment arms of the ANTICOV clinical trial
Fields of Study
Keywords
Sustainable Development Goals